[Recent therapeutic strategy for disseminated intravascular coagulation].
Hideo
H
Wada
Takeshi
T
Matsumoto
Yoshiki
Y
Yamashita
D000925:Anticoagulants / Q000008:administration & dosage; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D000991:Antithrombins / Q000008:administration & dosage; D001550:Benzamidines; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D005340:Fibrinogen / Q000008:administration & dosage; D016670:Gabexate / Q000008:administration & dosage; D006146:Guanidines / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D058990:Molecular Targeted Therapy; D010949:Plasma; D017713:Platelet Transfusion; D017410:Practice Guidelines as Topic; D015842:Serine Proteinase Inhibitors / Q000008:administration & dosage; D018180:Thrombomodulin / Q000008:administration & dosage
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D000991:Antithrombins; D001550:Benzamidines; D006146:Guanidines; D015842:Serine Proteinase Inhibitors; D018180:Thrombomodulin; D016670:Gabexate; D005340:Fibrinogen; D006493:Heparin; C032855:nafamostat